Tag archive for ‘Fragile X Syndrome’
Gali Weinreb On Sunday, January 11th, 2015

ADHD treatment co Alcobra raises $26 million on Nasdaq

– The company plans a second Phase III trial in the US for ADHD, drawing lessons from the previous Phase III trial.   Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD), which is developing a drug for More...

Globes On Sunday, October 27th, 2013

Alcobra Raises $33 Million In Secondary Nasdaq Offering

– The ADHD treatment developer raised $27 million in its IPO in May. –     Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million in its secondary offering on Thursday. More...

Wordpress site Developed by Fixing WordPress Problems